A nurse is reinforcing teaching to a newly licensed nurse about risk factors for subarachnoid hemorrhage (SAH). Which of the following should the nurse include in the teaching?

A. Glatiramer acetate: Glatiramer acetate is an immunomodulatory drug used primarily to treat multiple sclerosis by reducing the frequency of relapses. It has no role in the treatment of spasm-induced incontinence and does not affect bladder muscle activity, making it irrelevant to the client’s condition.
B. Dulaglutide: Dulaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist used for the management of type 2 diabetes. It works by enhancing insulin secretion and slowing gastric emptying but has no effect on neurogenic bladder or incontinence associated with spinal cord injury.
C. Oxybutynin: Oxybutynin is an anticholinergic medication that relaxes the bladder's detrusor muscle, reducing urinary frequency and urgency. It is commonly prescribed for clients with neurogenic bladder or spasm-induced incontinence following spinal cord injury, making it the most appropriate choice.
D. Montelukast sodium: Montelukast sodium is a leukotriene receptor antagonist used to prevent asthma symptoms and allergic rhinitis. It does not affect bladder function or spasticity and would not be prescribed for incontinence related to spinal cord injury.

A. A decrease in intracellular fluid volume: A reduction in intracellular fluid volume often results from hypertonic conditions in the extracellular space, which can draw water out of cells. This shift can actually increase serum osmolality rather than decrease it.
B. An increase in hydrostatic pressure: Increased hydrostatic pressure promotes fluid movement from the vascular space into the interstitial tissues, contributing to edema. However, this does not significantly impact the concentration of solutes in the serum and therefore does not directly cause a decrease in osmolality.
C. An increase in serum sodium: Sodium is the main contributor to serum osmolality, so an increase in serum sodium raises osmolality. This is the opposite of what occurs in heart failure, where sodium levels are often diluted due to fluid retention.
D. An increase in vascular fluid volume: In heart failure, the kidneys retain fluid in response to decreased cardiac output, expanding the vascular volume. This excess water dilutes the concentration of solutes in the blood, such as sodium, leading to a decrease in serum osmolality.